A retrospective, cohort study to evaluate antitumor efficacy of Apatinib as a potential biomarker in patients with metastatic Gastric Cancer
Latest Information Update: 24 Jun 2017
At a glance
- Drugs Rivoceranib (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 24 Jun 2017 New trial record